139 related articles for article (PubMed ID: 38129870)
61. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
62. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
[TBL] [Abstract][Full Text] [Related]
63. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
64. MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway.
Qiu C; Su W; Shen N; Qi X; Wu X; Wang K; Li L; Guo Z; Tao H; Wang G; Chen B; Xiang H
BMC Cancer; 2020 Dec; 20(1):1187. PubMed ID: 33272245
[TBL] [Abstract][Full Text] [Related]
65. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
[TBL] [Abstract][Full Text] [Related]
66. CircRNA_103801 accelerates proliferation of osteosarcoma cells by sponging miR-338-3p and regulating HIF-1/Rap1/PI3K-Akt pathway.
Li ZQ; Wang Z; Zhang Y; Lu C; Ding QL; Ren R; Cheng BB; Lou LX
J Biol Regul Homeost Agents; 2021; 35(3):1021-1028. PubMed ID: 34157832
[TBL] [Abstract][Full Text] [Related]
67. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
Huang S; Jin A
J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
[TBL] [Abstract][Full Text] [Related]
68. Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway.
Zhao X; Fang Y; Wang X; Yang Z; Li D; Tian M; Kang P
Int J Oncol; 2020 Jan; 56(1):206-218. PubMed ID: 31746363
[TBL] [Abstract][Full Text] [Related]
69. Genipin Inhibits the Development of Osteosarcoma through PI3K/AKT Signaling Pathway.
Huang X; Jiwa H; Xu J; Zhang J; Huang Y; Luo X
Curr Pharm Des; 2023; 29(16):1300-1310. PubMed ID: 37157220
[TBL] [Abstract][Full Text] [Related]
70. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
[TBL] [Abstract][Full Text] [Related]
72. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway.
Hao L; Liao Q; Tang Q; Deng H; Chen L
Biochem Biophys Res Commun; 2016 Feb; 470(3):643-649. PubMed ID: 26797271
[TBL] [Abstract][Full Text] [Related]
73. STEAP2 promotes osteosarcoma progression by inducing epithelial-mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2.
Zhang D; Liu H; Wang W; Xu G; Yin C; Wang S
Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 36316642
[TBL] [Abstract][Full Text] [Related]
74. ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway.
Cui Y; Dong YY
Aging (Albany NY); 2022 Sep; 14(18):7505-7516. PubMed ID: 36126191
[TBL] [Abstract][Full Text] [Related]
75. Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents
Su Q; Xu B; Tian Z; Gong Z
Acta Pharm; 2022 Sep; 72(3):389-402. PubMed ID: 36651540
[TBL] [Abstract][Full Text] [Related]
76. Lupeol suppresses migration and invasion
Hsu MJ; Peng SF; Chueh FS; Tsai CH; Tsai FJ; Huang CY; Tang CH; Yang JS; Hsu YM; Huang WW; Chung JG
Biosci Biotechnol Biochem; 2019 Sep; 83(9):1729-1739. PubMed ID: 31010399
[TBL] [Abstract][Full Text] [Related]
77. VEGF Silencing Inhibits Human Osteosarcoma Angiogenesis and Promotes Cell Apoptosis via PI3K/AKT Signaling Pathway.
Zhao J; Zhang ZR; Zhao N; Ma BA; Fan QY
Cell Biochem Biophys; 2015 Nov; 73(2):519-525. PubMed ID: 27352347
[TBL] [Abstract][Full Text] [Related]
78. SPOP suppresses osteosarcoma invasion via PI3K/AKT/NF-κB signaling pathway.
Chen L; Pei H; Lu SJ; Liu ZJ; Yan L; Zhao XM; Hu B; Lu HG
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):609-615. PubMed ID: 29461588
[TBL] [Abstract][Full Text] [Related]
79. Hox transcript antisense RNA knockdown inhibits osteosarcoma progression by regulating the phosphoinositide 3-kinase/AKT pathway through the microRNA miR-6888-3p/spleen tyrosine kinase axis.
Wu W; Wang L; Li S
Bioengineered; 2022 Apr; 13(4):9397-9410. PubMed ID: 35435107
[TBL] [Abstract][Full Text] [Related]
80. The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway.
Wang S; Zhao G; Zhao S; Qiao Y; Yang H
Med Sci Monit; 2020 Apr; 26():e920766. PubMed ID: 32312946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]